Author: Rebecca Shover
Second Opinion
Jul 30, 2022
“Consider this a second opinion, since you didn’t listen to anything I said the first...
Read MoreYou Have Influenza
Jul 27, 2022
“I’m sorry, the computer made an error. You’re not influential, you have...
Read MorePuberty, Part II
Jul 20, 2022
“Many women fear the word ‘menopause’, so I prefer to call it Puberty, Part...
Read MoreMedical Experts
Jul 13, 2022
“Follow every word of advice from every medical expert on TV, radio, books, magazines and...
Read MoreQuadruple Therapy Phase II Data for EGFR-mutated NSCLC
Jul 11, 2022
Atezolizumab plus bevacizumab plus carboplatin plus paclitaxel (ABCP) is a promising regimen for...
Read MoreDetermining Whether Adding RP1 to Cemiplimab Helps CSCC Patients
Jun 30, 2022
A presentation at the American Society of Clinical Oncology (ASCO) 2022 Annual meeting, which was...
Read MoreAcalabrutinib Still Outperforming in R/R CLL: Three-years Follow-up of ASCEND
Jun 27, 2022
A presentation at the American Society of Clinical Oncology (ASCO) 2022 Annual meeting, which was...
Read MoreDr. MedLaw: Restrictive Covenant
Jun 22, 2022
Q: All the employed doctors at my hospital, even those who were not up for contract renewal, just...
Read MoreOS benefit seen in 5-year data on ELEVATE-TN trial in CLL
Jun 21, 2022
A presentation at the American Society of Clinical Oncology (ASCO) 2022 Annual meeting, which was...
Read More